Yesterday 22 CEOs from Member State Biotech companies, together with representatives of 11 National
Biotech Associations, converged on Europe’s capital for EuropaBio Brussels Day and a series of
meetings with EU decision makers.
Today, Europabio joins in congratulating the three Nobel Prize winning scientists who have discovered
that the key to successful DNA replication is in the caps at the ends of chromosomes - the telomeres -
and in the enzyme that forms them - telomerase.
EuropaBio, the European Association for Bioindustries, and Venture Valuation, with the collaboration of
national stakeholders, yesterday published a ground-breaking report “Biotech in the new EU Member
States: an emerging sector”...
On June 9, Health Ministers from the 27 EU Member States unanimously signed up to a series of political commitments on behalf of Europe’s rare disease patients, by adopting a Council Recommendation on a European Action in the Field of Rare Diseases.
Better science, better regulation and better access policies are needed in Europe to support an innovative healthcare industry and the bio-pharmaceutical industry to deliver state-of-the-art standards of prevention, treatment and cures for EU citizens.
Taking the opportunity of the third European Patients’ Rights Day, EuropaBio, the EU Association for Bioindustries, reiterates the call to European Institutions and national governments for the involvement of patients in all EU political debates about healthcare.